These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 15713681

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2004 Oct 22; 279(43):45121-9. PubMed ID: 15308656
    [Abstract] [Full Text] [Related]

  • 3. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH, Rapti M, Knaüper V, Murphy G.
    J Biol Chem; 2004 Apr 23; 279(17):17562-9. PubMed ID: 14734567
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase.
    Lee MH, Knäuper V, Becherer JD, Murphy G.
    Biochem Biophys Res Commun; 2001 Jan 26; 280(3):945-50. PubMed ID: 11162616
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
    Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, Lin MF, Batra SK.
    Int J Oncol; 2003 Nov 26; 23(5):1365-71. PubMed ID: 14532978
    [Abstract] [Full Text] [Related]

  • 12. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex.
    Wisniewska M, Goettig P, Maskos K, Belouski E, Winters D, Hecht R, Black R, Bode W.
    J Mol Biol; 2008 Sep 19; 381(5):1307-19. PubMed ID: 18638486
    [Abstract] [Full Text] [Related]

  • 13. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.
    Lee MH, Dodds P, Verma V, Maskos K, Knäuper V, Murphy G.
    Biochem J; 2003 Apr 15; 371(Pt 2):369-76. PubMed ID: 12556225
    [Abstract] [Full Text] [Related]

  • 14. Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
    Nagase H, Brew K.
    Biochem Soc Symp; 2003 Apr 15; (70):201-12. PubMed ID: 14587293
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Unveiling the surface epitopes that render tissue inhibitor of metalloproteinase-1 inactive against membrane type 1-matrix metalloproteinase.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2003 Oct 10; 278(41):40224-30. PubMed ID: 12869573
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells.
    Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ, Fang KC.
    J Biol Chem; 2004 Feb 13; 279(7):5612-20. PubMed ID: 14625290
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination of tumor necrosis factor-alpha ablation and matrix metalloproteinase inhibition prevents heart failure after pressure overload in tissue inhibitor of metalloproteinase-3 knock-out mice.
    Kassiri Z, Oudit GY, Sanchez O, Dawood F, Mohammed FF, Nuttall RK, Edwards DR, Liu PP, Backx PH, Khokha R.
    Circ Res; 2005 Aug 19; 97(4):380-90. PubMed ID: 16037568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.